Patent · US Expired

High efficiency translation of mRNA molecules

US5807707A · kind A · utility

60Cited by
7References
37Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 12, 1996
Grant dateSep 15, 1998
Priority date
Expiry dateFeb 12, 2016

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N15/67
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

An increased level of translation of a selected mRNA molecule is effected by coupling specific nucleotide sequences at the 5'- and 3' -ends of a nucleic acid molecule transcribable to or which itself is the mRNA molecule. The nucleotide sequence at the 5'-end is effective to increase the rate of translation initiation of the mRNA molecule in a cell while the nucleotide sequence at the 3'-end is effective to increase the period of translation of the mRNA molecule in a cell. The nucleotide sequence of the 3'-end is provided by a 3'-untranslated region (3'-UTR) of a gene, particularly that of .beta.-prolactin, or an effective fragment thereof. A polyadenylation sequence preferably is provided at the 3'-end of the 3'-UTR sequence. The 3'-UTR sequence provides mRNA stabilization independent of the poly A tail.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.